Understand the source comparison
Peptides for Neck Rejuvenation Protocol Evidence Guide: Comparison Table
Before applying any peptide protocol, understand what each compound targets and what evidence supports its use. The table below compares the primary peptides referenced in neck rejuvenation research. GHK-Cu (Copper Peptide) 340 Da TGF-β activation, MMP inhibit
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before applying any peptide protocol, understand what each compound targets and what evidence supports its use. The table below compares the primary peptides referenced in neck rejuvenation research.
- GHK-Cu (Copper Peptide)
- 340 Da
- TGF-β activation, MMP inhibition, fibroblast proliferation
- Strong. Multiple RCTs showing dermal thickness increase
- 0.5–2% in serum
- Best-supported for dermal remodeling; requires consistent 12+ week use
- Matrixyl (Palmitoyl Pentapeptide-4)
- 580 Da
- Collagen fragment signaling, procollagen I/III upregulation
- Moderate. In vitro and small clinical trials
- 3–5% in formulations
- Works if delivered via liposomal carrier; standalone topical penetration limited
- Argireline (Acetyl Hexapeptide-8)
- 889 Da
- SNARE complex inhibition, reduced muscle contraction
- Weak for neck. Facial data only
- 5–10% in targeted serums
- Adjunct for platysmal banding; not a collagen synthesis driver
- Growth Hormone Peptides (e.g., Ipamorelin, CJC-1295)
- 2000+ Da
- Systemic GH secretion, IGF-1 elevation
- Investigational. No cosmetic trials
- Injectable only (subcutaneous)
- Research-grade only; systemic effects require medical oversight